Form 4: Okta Legal Officer Sells $301K in Stock Under 10b5-1 Plan
Insider Transaction Report
Okta's Chief Legal Officer, Larissa Schwartz, sold 3,348 shares of Class A Common Stock for approximately $301,916 under a pre-arranged 10b5-1 trading plan.
Summary
- Larissa Schwartz, Okta's Chief Legal Officer and Corporate Secretary, reported the sale of 3,348 shares of Class A Common Stock.
- The sales occurred on September 17, 2025, pursuant to a Rule 10b5-1 trading plan adopted on September 30, 2024.
- The shares were sold in two transactions: 1,400 shares at a weighted average price of $89.8257 and 1,948 shares at a weighted average price of $90.4102.
- Total proceeds from these sales amounted to approximately $301,916.27.
- Following these transactions, Ms. Schwartz directly beneficially owns 39,155 shares of Class A Common Stock.
- Ms. Schwartz also holds 51,844 unvested Restricted Stock Units (RSUs) across several grants, which are subject to various quarterly vesting schedules contingent on continuous employment.
Sentiment
Score: 5
Explanation: The sentiment is neutral. The sale is a routine insider transaction executed under a pre-arranged 10b5-1 plan, which typically indicates planned diversification or liquidity rather than a reaction to new company-specific information. The amount sold is not exceptionally large relative to the company's market capitalization.
Positives
- The transaction was executed under a pre-arranged Rule 10b5-1 trading plan, indicating a planned diversification or liquidity event rather than a reaction to new, negative information.
Negatives
- Insider sales, even planned ones, can sometimes be perceived by the market as a lack of confidence, though this is often mitigated by the existence of a 10b5-1 plan.
Risks
- No specific risks are mentioned in this Form 4 filing beyond the general market perception of insider sales.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
This filing is a routine disclosure of an insider stock transaction and does not provide information to analyze broader industry trends or competitor activities.
Stakeholder Impact
- Shareholders may perceive the insider sale as a minor signal, but the pre-arranged nature of the 10b5-1 plan mitigates concerns about management's confidence in the company's future.
Next Steps
- Remaining 316 RSUs will vest in 15 equal quarterly installments after March 15, 2022, subject to continuous employment.
- Remaining 217 RSUs will vest in 15 equal quarterly installments after June 15, 2022, subject to continuous employment.
- Remaining 8,891 RSUs will vest in 11 equal quarterly installments after June 15, 2023, subject to continuous employment.
- Remaining 11,620 RSUs will vest in 11 equal quarterly installments after June 15, 2024, subject to continuous employment.
- Remaining 30,800 RSUs will vest in 11 equal quarterly installments after June 15, 2025, subject to continuous employment.
- Continued compliance with the Rule 10b5-1 trading plan for any future planned transactions.
Key Dates
| Date | Description |
|---|---|
| 03/15/2022 | First vesting date for 6.25% of shares underlying 316 RSUs, with remaining shares vesting in 15 equal quarterly installments. |
| 06/15/2022 | First vesting date for 6.25% of shares underlying 217 RSUs, with remaining shares vesting in 15 equal quarterly installments. |
| 06/15/2023 | First vesting date for 8.33% of shares underlying 8,891 RSUs, with remaining shares vesting in 11 equal quarterly installments. |
| 06/15/2024 | First vesting date for 8.33% of shares underlying 11,620 RSUs, with remaining shares vesting in 11 equal quarterly installments. |
| 09/30/2024 | Rule 10b5-1 trading plan adopted by the Reporting Person. |
| 06/15/2025 | First vesting date for 8.33% of shares underlying 30,800 RSUs, with remaining shares vesting in 11 equal quarterly installments. |
| 09/17/2025 | Date of Class A Common Stock sales. |
| 09/19/2025 | Signature date of the Form 4 filing. |
Recommendation
holdA 'hold' recommendation is appropriate as this Form 4 filing details a routine, pre-planned insider stock sale. Such transactions, especially when executed under a 10b5-1 plan, typically do not provide sufficient new information to warrant a change in investment thesis or a strong buy/sell recommendation. The sale is likely for personal financial planning or diversification.
Keywords
Okta, OKTA, insider trading, Form 4, stock sale, executive compensation, Rule 10b5-1, Restricted Stock Units, RSU
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.